Although future precise manipulation of RNF43 in more relevant cell models (i.e., colon cancer cell lines (53)) are warranted, these early stage results in the HEK293T cell model have clearly shown the feasibility of programming successive point mutation and reversion using PE. This evidence concerns the gene RNF43 and malignant colon neoplasm.